| Product Name | MF | CAS | Details |
|---|
| 1-[(Pyrrolidin-1-yl)methyl]pyrrolidine | C9H18N2 | 7309-47-9 | Details |
| DYNC1I1 Blocking Peptide | Details |
| 5-Methyl-2-sulfanyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one | C6H6N4OS | 41122-81-0 | Details |
| R 406 free base | C22H23FN6O5 | 841290-80-0 | Details |
| 3',5'-Di-O-acetyl O6-benzyl-2'-deoxyguanosine | C21H23N5O6 | 144640-75-5 | Details |
| Nisoldipine-d6 | C20H24N2O6 | 1285910-03-3 | Details |
| N-Nitroso-di-n-butylamine | C8H18N2O | 924-16-3 | Details |
| 10,12-Heptacosadiynoic Acid | C27H46O2 | 67071-94-7 | Details |
| 2-chloro-5-formyl-4-picoline | C7H6ClNO | 884495-38-9 | Details |
| D-Tagatose 1-phosphate | C6H13O9P | 63323-90-0 | Details |
| OAZ3 Blocking Peptide | Details |
| cGMP Dependent Kinase Inhibitor Peptide | C38H74N18O10 | 82801-73-8 | Details |
| [2-Bromo-5-(difluoromethoxy)phenyl]methanol | C8H7BrF2O2 | 1427432-33-4 | Details |
| 3-{1-[(2-Chlorophenyl)methyl]-2,5-dimethyl-1H-pyrrol-3-yl}-3-oxopropanenitrile | C16H15ClN2O | 568574-79-8 | Details |
| (1,3-Dimethylcyclobutyl)methanamine hydrochloride | 2228290-27-3 | Details |
| 3,3-Diethylpiperidine-2,4-dione | C9H15NO2 | 77-03-2 | Details |
| 3-Bromo-2-hydroxy-5-iodopyridine | C5H3BrINO | 637348-81-3 | Details |
| [Arg14,Lys15]Nociceptin | C82H137N31O22 | 236098-40-1 | Details |
| Peonidin-3,5-diglucoside chloride | C28H33ClO16 | 132-37-6 | Details |
| VOPP1 antibody (FITC) | Details |
| 2-Chloro-5-(1-ethoxyethenyl)pyrazine | C8H9ClN2O | 1206723-31-0 | Details |
| Dibromodibenzo(b,def)chrysene-7,14-dione | C24H10Br2O2 | 1324-11-4 | Details |
| 3-Bromo-6-methylpyridine-2-carbonitrile | C7H5BrN2 | 717843-48-6 | Details |
| mPEG11-CH2CH2COOH | C26H52O14 | Details |
| LM22A-4 - Bio-X ? | C15H21N3O6 | 37988-18-4 | Details |
| 2-Bromo-6-methoxyaniline hydrochloride | C7H9BrClNO | 861084-02-8 | Details |
| 4-(Methoxymethyl)thiophene-2-carboxylic acid | C7H8O3S | 54796-49-5 | Details |
| Trans-2-tert-butoxycarbonylamino-1-methyl-cyclopentanecarboxylic acid | C12H21NO4 | 1965310-36-4 | Details |
| L-Cysteic acid | C3H7NO5S | 498-40-8 | Details |
| RGS7 antibody | Details |
| rac-Ethyl (1R,2R,4R,5R)-5-aminobicyclo[2.2.1]heptane-2-carboxylate hydrochloride | 2287236-72-8 | Details |
| SIRT2 Inhibitor, AGK2 | C23H13Cl2N3O2 | 304896-28-4 | Details |
| 2,2'-Diamino-4,4'-bithiazole | C6H6N4S2 | 58139-59-6 | Details |
| 2-Fluoro-6-methylphenol | C7H7FO | 443-90-3 | Details |
| Nicotine-N-b-D-glucuronide-D3 | C16H20D3N2O7 | Details |
| Dolastatin 15 (5S)-1-[(2S)-O-(N,N-Dimethyl-Val-Val-N-Me-Val-Pro-Pro)-2-hydroxyisovaleryl]-2-oxo-4-methoxy-5-benzyl-3-pyrroline | C45H68N6O9 | 123884-00-4 | Details |
| 2-(2-Methylpropyl)-1H-1,3-benzodiazole-4-carboxylic acid | C12H14N2O2 | 1339385-93-1 | Details |
| 3-Bromo-1-(4-methylphenyl)piperidin-2-one | C12H14BrNO | 1341366-78-6 | Details |
| 1-[3-(Trifluoromethoxy)phenyl]cyclopropan-1-amine hydrochloride | C10H11ClF3NO | 1909319-32-9 | Details |
| Butanilicaine hydrochloride | C13H20Cl2N2O | 6027-28-7 | Details |
| 2-Hydroxy-2,3,3-trimethylbutanoic acid | C7H14O3 | 4026-21-5 | Details |
| Piperidin-4-yl methanesulfonate hydrochloride | C6H14ClNO3S | 1443980-05-9 | Details |
| SB 431542 | C22H16N4O3 | 301836-41-9 | Details |
| Tetracosane | C24H50 | 646-31-1 | Details |
| 2,3-Diphenyl-5-[(2-morpholinoethyl)imino]-2,5-dihydro-1,2,4-thiadiazole | C20H22N4OS | 1281681-54-6 | Details |
| Nuclear Pore Complex antibody | Details |
| Ac-YSPWTNF-OH | Details |
| 6-Fluoro L-DOPA hydrobromide salt | C9H11BrFNO4 | 154051-94-2 | Details |
| H-Tyr-Tyr-OH | C18H20N2O5 | 1050-28-8 | Details |
| 3-Cyclopentyl-8-methyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine | C11H18N4 | 1250876-63-1 | Details |
| {5H,6H,7H-Cyclopenta[b]pyridin-7-yl}methanamine dihydrochloride | C9H13ClN2 | 1955530-22-9 | Details |
| 2-Methoxyethanethioamide | C3H7NOS | 15536-75-1 | Details |
| Mal-LQTLALWSRMD-OH | Details |
| Dansyl-Ala-Arg-OH trifluoroacetate salt | C21H30N6O5S | 87687-46-5 | Details |
| [D-Ala2,Met5]-beta-Casomorphin (1-5 , bovine ,amide | Details |
| Alprostadil alfadex | C56H94O35 | 55648-20-9 | Details |
| SGI 1776 | C20H22F3N5O.2(H2SO4) | 1173928-26-1 | Details |
| SHP099 Hydrochloride | C16H20Cl3N5 | 1801747-11-4 | Details |
| 1-(5,5-Dimethyl-4,5-dihydro-1,3-thiazol-2-yl)piperazine dihydrochloride | C9H19Cl2N3S | 1334148-37-6 | Details |
| 3-[Amino(carboxy)methyl]benzoic acid hydrochloride | C9H10ClNO4 | 156143-87-2 | Details |
| PALM antibody | Details |
| 1-(3'-O-Methyl-b-D-xylofuranosyl)-5-methyluracil | Details |
| (Ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl) dioctanoate | C22H42O6 | 106-10-5 | Details |
| H-HWESAS-OH | Details |
| (-)-Syringaresinol-4'-O-b-D-monoglucopyranoside | C28H36O13 | 137038-13-2 | Details |
| (S)-3-Amino-4-(2-fluorophenyl)butyric acid hydrochloride | C10H12FNO2 | 246876-92-6 | Details |
| PPARG antibody | Details |
| 5-(Trifluoromethyl)piperidin-2-one | C6H8F3NO | 50549-24-1 | Details |
| Pentacene (purified by sublimation) | C22H14 | 135-48-8 | Details |
| 2,2-Dimethyl-3-oxocyclobutane-1-carboxylic acid | C7H10O3 | 3183-43-5 | Details |
| 1-(4-Chloro-2-fluorophenyl)-1H,4H,5H,6H-cyclopenta[C]pyrazole-3-carboxylic acid | C13H10ClFN2O2 | 1152536-23-6 | Details |
| 5-(Piperidin-1-yl)isoquinolin-8-amine | C14H17N3 | 923211-75-0 | Details |
| 3-Methyl-2-phenylbutanal | C11H14O | 2439-44-3 | Details |
| Methyl 4,4,5,5,5-Pentafluoro-3-Oxopentanoate | C6H5F5O3 | 104857-88-7 | Details |
| N-(4-(methylpropyl)phenyl)-2-(2-pyridylthio)ethanamide | C17H20N2OS | 256955-15-4 | Details |
| Methyl 2-deoxy-D-threo-pentofuranoside | C6H12O4 | 863396-37-6 | Details |
| Methyl 2-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)acetate | C8H10N2O3 | 1803583-26-7 | Details |
| CD45.1 antibody (PE) | Details |
| N-{3-[(Methylamino)methyl]phenyl}benzenesulfonamide | C14H16N2O2S | 1156162-41-2 | Details |
| 3-Methyl-1-(propane-2-sulfonyl)piperidin-4-amine | C9H20N2O2S | 1376343-23-5 | Details |
| 7-Methyl-2,4-dioxo-1H,2H,3H,4H-pyrido[2,3-d]pyrimidine-5-carboxylic acid | C9H7N3O4 | 116081-01-7 | Details |
| Methyl 3-methyl-1,1-dioxo-4H-1,2,4-benzothiadiazine-7-carboxylate | C10H10N2O4S | 1197707-54-2 | Details |
| P2RX7 Blocking Peptide | Details |
| 5-Bromo-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione | C5H2BrF3N2O2 | 26676-21-1 | Details |
| 1-Amino-4-methoxy-2,3-dihydro-1H-indene-1-carboxylic acid hydrochloride | C11H14ClNO3 | 1803589-84-5 | Details |
| 1-(1-Methylpiperidin-4-yl)azetidine-3-carboxylic acid | C10H18N2O2 | 1466530-15-3 | Details |
| 2-Bromo-5-chlorobenzenesulfonyl chloride | C6H3BrCl2O2S | 1037299-72-1 | Details |
| Myocd Blocking Peptide | Details |
| 2-Chloro-N-({[1-(4-fluorophenyl)ethyl]carbamoyl}methyl)acetamide | C12H14ClFN2O2 | 1334147-23-7 | Details |
| 2-(Methylamino)-1,3-oxazole-4-carbonitrile | C5H5N3O | 2092267-82-6 | Details |
| 1-[4-(Cyclopropylmethoxy)-3-fluorophenyl]ethan-1-amine | C12H16FNO | 1019606-90-6 | Details |
| YedQ antibody | Details |
| 1,2:5,6-Di-O-isopropylidene-3,4-di-O-benzyl-D-myo-inositol | C26H32O6 | 131233-62-0 | Details |
| Ethyl 3-methyl-[1,2]oxazolo[5,4-b]pyridine-6-carboxylate | C10H10N2O3 | 950143-81-4 | Details |
| [1-(2-Methylpropyl)-1H-pyrazol-4-yl]methanamine | C8H15N3 | 1152576-43-6 | Details |
| N-[4-(Propan-2-yl)phenyl]benzenesulfonamide | C15H17NO2S | 116752-56-8 | Details |
| WBP2 Blocking Peptide | Details |
| 3-Methyl-2-(thiophene-2-sulfonylamino)-butyric acid | C9H13NO4S2 | 82068-14-2 | Details |
| 2-Hydroxy-N-(propan-2-yl)propanamide | C6H13NO2 | 6280-17-7 | Details |
| 4-(Hydroxymethyl)benzamide | C8H9NO2 | 87128-27-6 | Details |
| Product Total： Product Page： | ||||
| 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 | ||||